https://scholars.lib.ntu.edu.tw/handle/123456789/205288
DC Field | Value | Language |
---|---|---|
dc.contributor | 骨科 | en |
dc.contributor.author | FONG, YI-CHIN | en |
dc.contributor.author | MAA, MING-CHEI | en |
dc.contributor.author | TSAI, FUU- JEN | en |
dc.contributor.author | CHEN, WEN-CHI | en |
dc.contributor.author | LIN, JAUNG-GENG | en |
dc.contributor.author | JENG, LONG-BIN | en |
dc.contributor.author | YANG, RONG-SEN | en |
dc.contributor.author | FU, WEN-MEI | en |
dc.contributor.author | TANG, CHIH-HSIN | en |
dc.creator | 馮逸卿;馬明琪;蔡輔仁;陳文誌;林昭庚;鄭隆賓;楊榮森;符文美;湯智昕 | zh-tw |
dc.creator | FONG, YI-CHIN;MAA, MING-CHEI;TSAI, FUU- JEN;CHEN, WEN-CHI;LIN, JAUNG-GENG;JENG, LONG-BIN;YANG, RONG-SEN;FU, WEN-MEI;TANG, CHIH-HSIN | en |
dc.date | 2008 | en |
dc.date.accessioned | 2009-12-23T09:31:15Z | - |
dc.date.accessioned | 2018-07-13T16:57:36Z | - |
dc.date.available | 2009-12-23T09:31:15Z | - |
dc.date.available | 2018-07-13T16:57:36Z | - |
dc.date.issued | 2008 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/175240 | - |
dc.description.abstract | Introduction: The bone marrow microenvironment is further enriched by growth factors released during osteoclastic bone resorption. It has been reported that the chemokine interleukin (IL)-8 is a potent and direct activator of osteoclastic differentiation and bone resorption. However, the effect of bone-derived growth factors on the IL-8 production in human cancer cells and the promotion of osteoclastogenesis are largely unknown. The aim of this study was to investigate whether osteoblast-derived TGF- beta 1 is associated with osteolytic bone diseases. Materials and Methods: IL-8 mRNA levels were measured using RT-PCR analysis. MAPK phosphorylation was examined using the Western blot method. siRNA was used to inhibit the expression of TGF-beta 1, BMP-2, and IGF-1. DNA affinity protein-binding assay and chromatin immunoprecipitation assays were used to study in vitro and in vivo binding of c- fos, c-jun, p65, and p50 to the IL-8 promoter. A transient transfection protocol was used to examine IL-8, NF-kappa B, and activator protein (AP)-1 activity. Results: Osteoblast conditioned medium (OBCM) induced activation of IL-8, AP-1, and NF-kappa B promoter in human cancer cells. Osteoblasts were transfected with TGF-beta 1, BMP-2, or IGF-1 small interfering RNA, and the medium was collected after 48 h. TGF-beta 1 but not BMP-2 or IGF-1. siRNA inhibited OBCM- induced IL-8 release in human cancer cells. In addition, TGF -beta 1 also directly induced IL-8 release in human cancer cells. Activation of AP-1. and NF-kappa B DNA-protein binding and MAPKs after TGF-beta 1 treatment was shown, and TGF-beta 1-induced IL-8 promoter activity was inhibited by the specific inhibitors of MAPK cascades. Conclusions: In this study, we provide evidence to show that the osteoblasts release growth factors, including TGF-beta 1, BMP-2, and IGF-1. TGF-beta 1 is the major contributor to the activation of extracellular signal-related kinase (ERK), p38, and c- Jun N-terminal kinase (JNK), leading to the activation of AP -1 and NF-kappa B on the IL-8 promoter and initiation of IL- 8 mRNA and protein release, thereby promoting osteoclastogenesis. | en |
dc.language | en-us | en |
dc.language.iso | en_US | - |
dc.relation | JOURNAL OF BONE AND MINERAL RESEARCH v.23 n.6 pp.961-970 | en |
dc.relation.ispartof | JOURNAL OF BONE AND MINERAL RESEARCH | - |
dc.subject | osteoblasts | en |
dc.subject | interleukin-8 | en |
dc.subject | TGF-beta 1 | en |
dc.subject | NF-kappa B | en |
dc.subject | activator protein 1 | en |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | Osteoblast-Derived Tgf-Beta 1 Stimulates Il-8 Release through Ap-1 and Nf -Kappa B in Human Cancer Cells | en |
dc.relation.pages | 961-970 | - |
dc.relation.journalvolume | v.23 | - |
dc.relation.journalissue | n.6 | - |
item.languageiso639-1 | en_US | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.